Robin Lifton
Medical Oncology · Venice, FLNPI 1437140068
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.0% of the total across 167 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 8.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,363 and has fallen 96.3% since, to $50 in 2025. That places this record below the midpoint for medical oncology clinicians in FL, where the typical reported total is $8,890.
Across 167 payments — averaging $18.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$270
- Novartis$229
- Exelixis Inc.$222
- Pfizer$195
- E.r. Squibb & Sons, L.L.C.$194
- Bristol Myers Squibb$159
- plus $2K from 31 others
What the payments were for
- Food & beverage$3,06698%
- Education$612%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 20 | $270 |
| Novartis | 13 | $229 |
| Exelixis Inc. | 3 | $222 |
| Pfizer | 12 | $195 |
| E.r. Squibb & Sons, L.L.C. | 13 | $194 |
| Bristol Myers Squibb | 9 | $159 |
| Beigene USA, Inc. | 2 | $149 |
| Amgen | 12 | $141 |
| Astellas Pharma US Inc | 9 | $135 |
| Sanofi | 8 | $133 |
| Incyte Corporation | 6 | $125 |
| Jazz Pharmaceuticals Inc. | 2 | $121 |
| Merck | 7 | $110 |
| AstraZeneca | 3 | $94 |
| Genentech USA, Inc. | 6 | $92 |
| Regeneron Healthcare Solutions, Inc. | 3 | $88 |
| Bayer | 5 | $72 |
| Daiichi Sankyo Inc. | 3 | $66 |
| Lilly USA, LLC | 4 | $66 |
| Gilead(2 entities) | 4 | $61 |
| AbbVie | 3 | $58 |
| Seagen Inc. | 3 | $49 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $44 |
| Taiho Oncology, Inc. | 1 | $23 |
| Deciphera Pharmaceuticals Inc. | 1 | $23 |
| Rigel Pharmaceuticals, Inc. | 2 | $23 |
| EUSA Pharma (US) LLC | 1 | $21 |
| Karyopharm Therapeutics Inc. | 1 | $21 |
| Ipsen Biopharmaceuticals, Inc | 1 | $21 |
| Eisai Inc. | 1 | $20 |
| AMAG Pharmaceuticals, Inc. | 1 | $18 |
| Boehringer Ingelheim | 1 | $17 |
| Array Biopharma Inc | 1 | $15 |
| Partner Therapeutics, Inc. | 1 | $15 |
| Tersera Therapeutics LLC | 1 | $14 |
| AVEO Pharmaceuticals, Inc. | 1 | $14 |
| EMD Serono, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,127 in reported general payments places this provider in the 30th percentile of 507 medical oncology providers in Florida.
Other medical oncology in Venice
- Neil LoveMiami$5.6M
- Mahdi TahaBoca Raton$1.7M
- Raji ShameemOrlando$1.3M
- Mohammad JahanzebBoca Raton$1.3M
- Michel VelezOrlando$927K
- Yuanbin ChenOrlando$810K
- Reshma MahtaniPlantation$608K
- Rebecca MorooseOrlando$543K
- Yasser KhaledOrlando$444K
- Judah FriedmanPalm Beach Gardens$416K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.